IP Library Granted Patent US 8,657,447
Granted Patent B2
US 8,657,447 · App. 13/755,295 · Granted Feb 25, 2014

Methods and devices for measuring tear film and diagnosing tear disorders

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,657,447
App. No.
13/755,295
Granted
Feb 25, 2014
Kind
B2
Abstract

Methods and devices measure eye blinks and tear film lipid and aqueous layer thickness before and following ophthalmic formula application onto the ocular surface, especially wherein the ophthalmic formula is an artificial tear. The methods and devices are suitable for dry eye diagnosis. The methods and devices are suitable for use to evaluate ophthalmic formula effects on the tear film and to use such information to diagnose ophthalmic formula treatment of ocular disease conditions such as dry eye in the absence of contact lens wear or post-surgical eye drop treatment and diagnosis. The methods and devices are also suitable for use in the optimization of ophthalmic drug dosage forms and sustained drug release.

Claims (18)

1. A method of measuring the ocular comfort of a subject, the method comprising:

projecting a wavelength of light onto an ocular surface;

measuring light reflectance from the ocular surface over a period of time wherein the period of time is comprised of sequential time increments, and wherein the sequential time increments are smaller than a time when the light reflectance is blocked from being measured; and

analyzing the light reflectance over the period of time.

2. The method as in claim 1 , wherein said analyzing comprises analysis of light reflectance versus time.

3. The method as in claim 1 , wherein said analyzing comprises a determination of a number of reductions of light reflectance.

4. The method as in claim 1 , wherein said analyzing comprises a determination of a maximum time interval between reductions of light reflectance.

5. The method as in claim 1 , wherein the analyzing of light reflectance results in blink frequency data and further comprising the step of performing a fourier transformation on the blink frequency data comprising reductions of light reflectance over time.

6. A method of increasing ocular comfort of a subject, the method comprising:

projecting a wavelength of light onto an ocular surface;

measuring light reflectance from the ocular surface over a period of time, wherein the period of time is comprised of sequential time increments, and wherein the sequential time increments are smaller than a time when the light reflectance is blocked from being measured;

analyzing the light reflectance over the period of time; and

recommending an ophthalmic solution for use by the subject.

7. The method as in claim 6 , wherein said analyzing comprises analysis of light reflectance versus time.

8. The method as in claim 6 , wherein said analyzing comprises a determination of a number of reductions of light reflectance.

9. The method as in claim 6 , wherein said analyzing comprises a determination of a maximum time interval between reductions of light reflectance.

10. The method as in claim 6 , wherein the analyzing of light reflectance results in blink frequency data and further comprising the step of performing a fourier transformation on the blink frequency data comprising reductions of light reflectance over time.

11. The method as in claim 6 , wherein the ophthalmic solution contains an ingredient selected from the group consisting of methylcellulose, Dextran 70, Gelatin, glycerin, polyethylene glycol 300, polyethylene glycol 400, Polysorbate 80, propylene glycol, polyvinyl alcohol, povidone, hyaluronic acid, sodium hyaluronate, hydroxypropyl guar, tamarind seed polysaccharide, plant-derived polymers, polymeric materials having multiple anionic charges, anionic cellulose derivatives, anionic acrylic acid-containing polymers, anionic methacrylic acid-containing polymers, anionic amino acid-containing polymers, the salts of any of the foregoing and mixtures thereof.

Assignments (3)
CHANGE OF NAME Recorded Sep 25, 2018
From: ABBOTT MEDICAL OPTICS INC.
To: JOHNSON & JOHNSON SURGICAL VISION, INC.
Reel/Frame 047151/0121 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2013
From: HUTH, STAN; TRAN, DENISE
To: ADVANCED MEDICAL OPTICS, INC.
Reel/Frame 029729/0627 →
MERGER Recorded Jan 31, 2013
From: ADVANCED MEDICAL OPTICS, INC.
To: ABBOTT MEDICAL OPTICS INC.
Reel/Frame 029729/0646 →